uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted May 29, 2018

FDA Warns Seller of "Aromatase Inhibitor" Supplement

On May 18, 2018, the FDA issued a warning letter to Performance Nutrition Formulators LLC d.b.a. VMI Sports because its product Arimistane contains Androsta-3,5-Diene-7,17-Dione, an ingredient that the FDA considers to be a new drug and not a dietary supplement ingredient.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at